Jaguar Health Regains Nasdaq Public Shares Compliance, Secures Bid Price Extension to May 18
JAGX is trading near its 52-week low of $2.53 (14% above the low) on elevated volume (5.3× avg).
Summary
Jaguar Health announced it has regained compliance with Nasdaq's publicly held shares requirement, a positive development following a delisting notice on May 4th. Additionally, the company received an extension until May 18, 2026, to demonstrate compliance with the minimum $1.00 bid price rule. This extension was partially disclosed in an 8-K on May 7th. These actions provide a temporary reprieve from immediate delisting threats, which is crucial for the financially distressed company. Traders will closely watch the stock's performance to see if it can maintain the required bid price by the new deadline.
At the time of this announcement, JAGX was trading at $2.88 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2M. The 52-week trading range was $2.53 to $395.98. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Access Newswire.